Choices in vaccine trial design in epidemics of emerging infections

CEPI—a new global R&D organisation for epidemic preparedness and response

(2017) Børge Brende et al.   LANCET

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

(2017) Ana Maria Henao-Restrepo et al.   LANCET

Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger

(2017) Sheila Isanaka et al.   NEW ENGLAND JOURNAL OF MEDICINE

Spread of Zika virus in the Americas

(2017) Qian Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improving vaccine trials in infectious disease emergencies

(2017) Marc Lipsitch et al.   SCIENCE

Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine?

(2017) Bradford D. Gessner et al.   VACCINE

Ethical Rationale for the Ebola “Ring Vaccination” Trial Design

(2016) Annette Rid et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Statistics and logistics: Design of Ebola vaccine trials in West Africa

(2016) Martha Nason   Clinical Trials

Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges

(2016) Stephen B Kennedy et al.   Clinical Trials

Prioritization of healthcare workers for experimental Ebola therapeutic would exacerbate existing inequalities

(2015) Morenike Oluwatoyin Folayan et al.   Developing World Bioethics

Prioritising Healthcare Workers for Ebola Treatment: Treating Those at Greatest Risk to Confer Greatest Benefit

(2015) Priya Satalkar et al.   Developing World Bioethics

Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis

(2015) Steven E Bellan et al.   LANCET INFECTIOUS DISEASES

Ebola and beyond

(2015) M. Lipsitch et al.   SCIENCE

On the relative role of different age groups in influenza epidemics

(2015) Colin J. Worby et al.   Epidemics

Incorporating Contact Network Structure in Cluster Randomized Trials

(2015) Patrick C. Staples et al.   Scientific Reports

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites

(2014)   PLOS MEDICINE

Environmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009–2010

(2013) Amy Parker Fiebelkorn et al.   Human Vaccines & Immunotherapeutics

Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

(2013) Daniel R. Feikin et al.   PLOS MEDICINE

Cholera Modeling

(2012) Yonatan H. Grad et al.   EPIDEMIOLOGY

Understanding Reduced Rotavirus Vaccine Efficacy in Low Socio-Economic Settings

(2012) Benjamin A. Lopman et al.   PLoS One

Spectrum Bias and Loss of Statistical Power in Discordant Couple Studies of Sexually Transmitted Infections

(2010) Ashleigh R. Tuite et al.   SEXUALLY TRANSMITTED DISEASES